IRIS
BATTIPAGLIA, GIORGIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 396
AS - Asia 169
EU - Europa 158
AF - Africa 21
OC - Oceania 1
Totale 745
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 395
SG - Singapore 154
IT - Italia 67
NL - Olanda 42
CI - Costa d'Avorio 21
IE - Irlanda 14
PL - Polonia 12
IN - India 8
CN - Cina 7
DE - Germania 7
BE - Belgio 3
UA - Ucraina 3
FI - Finlandia 2
GB - Regno Unito 2
AL - Albania 1
AU - Australia 1
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
FR - Francia 1
HR - Croazia 1
HU - Ungheria 1
Totale 745
Salva come PNG Salva come JPEG
Città #
Singapore 128
Santa Clara 77
Amsterdam 42
Lawrence 33
Boston 30
Des Moines 23
Millbury 21
Naples 16
Chandler 14
Dublin 12
Gdansk 11
Ashburn 10
Wilmington 10
Woodbridge 7
Milan 6
Mumbai 6
Nuremberg 6
Arezzo 5
Fairfield 4
Camponogara 3
Genoa 3
Jacksonville 3
Nanjing 3
Washington 3
Bagnacavallo 2
Bengaluru 2
Bologna 2
Catania 2
Courcelles 2
La Spezia 2
Latina 2
Lentini 2
Olbia 2
Palermo 2
Qualiano 2
Rome 2
Shenyang 2
Angers 1
Barcelona 1
Beijing 1
Brussels 1
Budapest 1
Fort St. James 1
Melbourne 1
Mountain View 1
Osio Sotto 1
Poznan 1
Princeton 1
Redwood City 1
Scottsdale 1
Shenzhen 1
Tirana 1
Zagreb 1
Totale 518
Salva come PNG Salva come JPEG
Nome #
JAK2V617F mutation persists in blasts and mature cells of transformed JAK2V617F-positive-myeloproliferative neoplasia: a European Leukemia Net (ENL) study. 37
Hematopoietic cell transplant nurse coordinators’ perceptions of related donor care: a European survey from the EBMT Nurses Group 37
Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience 31
Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML). 30
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French–Italian 10-year experience on 228 patients 24
Extracorporeal photopheresis as first-line strategy in the treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: a single-center experience 24
Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria 23
Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia 23
Medication adherence among allogeneic hematopoietic stem cell transplant recipients: A pilot single-center study 20
Thiotepa and antithymocyte globulin-based conditioning prior to haploidentical transplantation with posttransplant cyclophosphamide in high-risk hematological malignancies 20
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 20
CD34+-selected stem cell “Boost” for poor graft function after allogeneic hematopoietic stem cell transplantation 19
Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting 19
Tolerability and Efficacy of Treatment With Azacytidine as Prophylactic or Preemptive Therapy for Myeloid Neoplasms After Allogeneic Stem Cell Transplantation 18
Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation 18
Pre-emptive rituximab treatment for Epstein–Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes 18
Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An Update 17
Defibrotide for Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Prophylaxis in High-Risk Adult Patients: A Single-Center Experience Study 17
Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation 17
Infectious complications after post-transplantation cyclophosphamide and anti-thymocyte globulin-based haploidentical stem cell transplantation 17
Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT 17
Posttransplant cyclophosphamide vs antithymocyte globulin in HLA-mismatched unrelated donor transplantation 16
Unmanipulated haploidentical versus HLA-matched sibling allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a retrospective study on behalf of the ALWP of the EBMT 16
Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients 16
Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation 16
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? 16
Inhibition of FLT3 in AML: A focus on sorafenib 16
The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT) 16
Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors 15
Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia 15
Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: A report of the EBMT Acute Leukemia Working Party 15
Transmission of Legionnaires' Disease through Toilet Flushing 15
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT 15
Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: An ALWP-EBMT study 14
Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia 13
Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: A study from the acute leukemia working party of the european society for blood and marrow transplantation 12
Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation 12
New strategies of allogeneic hematopoietic stem cell transplantation with the use of haploidentical donors 12
Rhino-orbital Mucormycosis presenting as facial cellulitis in a patient with high-risk acute myeloid leukemia in relapse 11
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: A retrospective study from the Acute Leukemia Working Party of the EBMT 11
High-dose post-transplant cyclophosphamide impairs γδ T-cell reconstitution after haploidentical haematopoietic stem cell transplantation using low-dose antithymocyte globulin and peripheral blood stem cell graft 10
Immune restoration therapy for multidrug-resistant CMV disease in an allogenic stem cell transplant recipient 10
Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation 10
Allogeneic Stem Cell Transplantation for FLT3-Mutated Acute Myeloid Leukemia: In vivo T-Cell Depletion and Posttransplant Sorafenib Maintenance Improve Survival. A Retrospective Acute Leukemia Working Party-European Society for Blood and Marrow Transplant Study 9
Congress report: European Group for Blood and Marrow Transplantation (EBMT) 2015 8
Impact of gut fungal and bacterial communities on the outcome of allogeneic hematopoietic cell transplantation 7
Prognostic impact of early minimal residual disease combined with complete molecular evaluation in acute myeloid leukemia with mutated NPM1: a single center study 3
Totale 795
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.223
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202046 0 0 0 0 0 0 0 0 0 0 0 46
2020/202124 6 0 1 1 6 2 2 0 1 0 1 4
2021/202297 0 0 0 0 0 0 0 6 9 1 4 77
2022/2023155 34 0 0 1 3 12 3 17 20 43 16 6
2023/2024223 7 31 20 9 58 1 8 31 1 3 32 22
2024/2025239 73 109 0 5 52 0 0 0 0 0 0 0
Totale 795